{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53172"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53172","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Long COVID-associated chronic fatigue syndrome and brain fog: a review","abstract":"Long COVID (LC) presents with persistent, multisystem symptoms that frequently overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and brain fog. This thesis explores their shared features, emphasizing converging biological mechanisms across immune, neural, vascular, virological, and gastrointestinal systems. It also reviews diagnostic tools such as the Stroop task, DSQ-SF, MBSQ, ICD-10 surveillance, and the Turkish Brain Fog Scale, which may improve detection of underrecognized symptoms, particularly cognitive dysfunction. Therapeutic approaches are assessed across pharmaceutical, blood-derived, and rehabilitative strategies, including interventions targeting muscle strength, gut health, and motor coordination. Despite growing research, brain fog remains poorly understood, with limited tools for measurement and treatment. The lack of diagnostic clarity continues to hinder clinical care across these overlapping conditions. This thesis highlights the urgent need to better define and address post-viral syndromes. Advancing understanding of the connections between LC, ME/CFS, and brain fog is essential for improving diagnosis, guiding targeted treatment, and reducing the long-term burden on patients.","abstract_html":"Long COVID (LC) presents with persistent, multisystem symptoms that frequently overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and brain fog. This thesis explores their shared features, emphasizing converging biological mechanisms across immune, neural, vascular, virological, and gastrointestinal systems. It also reviews diagnostic tools such as the Stroop task, DSQ-SF, MBSQ, ICD-10 surveillance, and the Turkish Brain Fog Scale, which may improve detection of underrecognized symptoms, particularly cognitive dysfunction. Therapeutic approaches are assessed across pharmaceutical, blood-derived, and rehabilitative strategies, including interventions targeting muscle strength, gut health, and motor coordination. Despite growing research, brain fog remains poorly understood, with limited tools for measurement and treatment. The lack of diagnostic clarity continues to hinder clinical care across these overlapping conditions. This thesis highlights the urgent need to better define and address post-viral syndromes. Advancing understanding of the connections between LC, ME/CFS, and brain fog is essential for improving diagnosis, guiding targeted treatment, and reducing the long-term burden on patients.","abstract_has_math":false,"creators":["Kim, Daniel H."],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Symes, Karen","Nolan, Anna"],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-18T20:19:39Z","subjects":["Public health","Immunology","Neurosciences","Brain fog","Diagnostic tools","Immune dysfunction","Long COVID","Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)","Therapeutic interventions"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0005-8775-4685"],"render_values":[{"text":"0009-0005-8775-4685","href":"https://orcid.org/0009-0005-8775-4685","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/53172","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53172","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53172","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Symes, Karen","Nolan, Anna"]},{"key":"dc:creator","label":"Author","values":["Kim, Daniel H."]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0005-8775-4685"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-06-17T17:45:53Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-06-17T17:45:53Z"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-06-17T16:05:55Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Public health","Immunology","Neurosciences","Brain fog","Diagnostic tools","Immune dysfunction","Long COVID","Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)","Therapeutic interventions"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53172"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2025"]},{"key":"dc:description.abstract","label":"Abstract","values":["Long COVID (LC) presents with persistent, multisystem symptoms that frequently overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and brain fog. This thesis explores their shared features, emphasizing converging biological mechanisms across immune, neural, vascular, virological, and gastrointestinal systems. It also reviews diagnostic tools such as the Stroop task, DSQ-SF, MBSQ, ICD-10 surveillance, and the Turkish Brain Fog Scale, which may improve detection of underrecognized symptoms, particularly cognitive dysfunction. Therapeutic approaches are assessed across pharmaceutical, blood-derived, and rehabilitative strategies, including interventions targeting muscle strength, gut health, and motor coordination. Despite growing research, brain fog remains poorly understood, with limited tools for measurement and treatment. The lack of diagnostic clarity continues to hinder clinical care across these overlapping conditions. This thesis highlights the urgent need to better define and address post-viral syndromes. Advancing understanding of the connections between LC, ME/CFS, and brain fog is essential for improving diagnosis, guiding targeted treatment, and reducing the long-term burden on patients."]},{"key":"dc:title","label":"Title","values":["Long COVID-associated chronic fatigue syndrome and brain fog: a review"]}]}],"canonical_facts":{"dc:contributor.advisor":["Symes, Karen","Nolan, Anna"],"dc:creator":["Kim, Daniel H."],"dc:date.accessioned":["2026-06-17T17:45:53Z"],"dc:date.available":["2026-06-17T17:45:53Z"],"dc:date.issued":["2025"],"dc:date.updated":["2026-06-17T16:05:55Z"],"dc:description":["2025"],"dc:description.abstract":["Long COVID (LC) presents with persistent, multisystem symptoms that frequently overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and brain fog. This thesis explores their shared features, emphasizing converging biological mechanisms across immune, neural, vascular, virological, and gastrointestinal systems. It also reviews diagnostic tools such as the Stroop task, DSQ-SF, MBSQ, ICD-10 surveillance, and the Turkish Brain Fog Scale, which may improve detection of underrecognized symptoms, particularly cognitive dysfunction. Therapeutic approaches are assessed across pharmaceutical, blood-derived, and rehabilitative strategies, including interventions targeting muscle strength, gut health, and motor coordination. Despite growing research, brain fog remains poorly understood, with limited tools for measurement and treatment. The lack of diagnostic clarity continues to hinder clinical care across these overlapping conditions. This thesis highlights the urgent need to better define and address post-viral syndromes. Advancing understanding of the connections between LC, ME/CFS, and brain fog is essential for improving diagnosis, guiding targeted treatment, and reducing the long-term burden on patients."],"dc:identifier.orcid":["0009-0005-8775-4685"],"dc:identifier.uri":["https://hdl.handle.net/2144/53172"],"dc:language.iso":["en_US"],"dc:subject":["Public health","Immunology","Neurosciences","Brain fog","Diagnostic tools","Immune dysfunction","Long COVID","Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)","Therapeutic interventions"],"dc:title":["Long COVID-associated chronic fatigue syndrome and brain fog: a review"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T20:19:39Z"}